Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

BACKGROUND and AIMS: Cytotoxic T cells have been suggested to be responsible for lysis of hepatitis B virus (HBV)-infected hepatocytes and control of virus infection. The frequency, kinetics, phenotype, and capacity for clonal expansion of circulating HBV-specific CD8 cells were analyzed directly in...

Full description

Bibliographic Details
Main Authors: Maini, M, Boni, C, Ogg, G, King, A, Reignat, S, Lee, C, Larrubia, JR, Webster, G, Mcmichael, A, Ferrari, C, Williams, R, Vergani, D, Bertoletti, A
Format: Journal article
Language:English
Published: 1999
_version_ 1797063046120603648
author Maini, M
Boni, C
Ogg, G
King, A
Reignat, S
Lee, C
Larrubia, JR
Webster, G
Mcmichael, A
Ferrari, C
Williams, R
Vergani, D
Bertoletti, A
author_facet Maini, M
Boni, C
Ogg, G
King, A
Reignat, S
Lee, C
Larrubia, JR
Webster, G
Mcmichael, A
Ferrari, C
Williams, R
Vergani, D
Bertoletti, A
author_sort Maini, M
collection OXFORD
description BACKGROUND and AIMS: Cytotoxic T cells have been suggested to be responsible for lysis of hepatitis B virus (HBV)-infected hepatocytes and control of virus infection. The frequency, kinetics, phenotype, and capacity for clonal expansion of circulating HBV-specific CD8 cells were analyzed directly in patients with acute HBV infection to clarify their pathogenetic role. METHODS: Three HLA-A2 peptide tetramers able to visualize HBV core, envelope, and polymerase epitope-specific cytotoxic T lymphocytes were synthesized and used for flow cytometric analysis of antigen-specific populations. RESULTS: Tetramer-positive cells specific for the core 18-27 epitope were found at a higher frequency than those specific for polymerase 575-583 and envelope 335-343 epitopes in most patients with acute HBV. The number of HBV-specific CD8 cells was highest during the clinically acute stage of infection and decreased after recovery. These cells expressed an activated phenotype and had an impaired capacity to expand in vitro and to display cytolytic activity in response to peptide stimulation. Recovery of these functions was observed when the frequency of specific CD8 cells decreased, coincident with a progressive decrease in their expression of activation markers. CONCLUSIONS: This study provides the first ex vivo evidence that the highest frequency of circulating HBV-specific CD8 cells coincides with the clinically acute phase of hepatitis B. These cells exhibit an activated phenotype with limited further proliferative capacity that is restored during recovery.
first_indexed 2024-03-06T20:54:15Z
format Journal article
id oxford-uuid:38a190a6-f80d-4716-9fa1-6ac169a00e43
institution University of Oxford
language English
last_indexed 2024-03-06T20:54:15Z
publishDate 1999
record_format dspace
spelling oxford-uuid:38a190a6-f80d-4716-9fa1-6ac169a00e432022-03-26T13:51:19ZDirect ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:38a190a6-f80d-4716-9fa1-6ac169a00e43EnglishSymplectic Elements at Oxford1999Maini, MBoni, COgg, GKing, AReignat, SLee, CLarrubia, JRWebster, GMcmichael, AFerrari, CWilliams, RVergani, DBertoletti, ABACKGROUND and AIMS: Cytotoxic T cells have been suggested to be responsible for lysis of hepatitis B virus (HBV)-infected hepatocytes and control of virus infection. The frequency, kinetics, phenotype, and capacity for clonal expansion of circulating HBV-specific CD8 cells were analyzed directly in patients with acute HBV infection to clarify their pathogenetic role. METHODS: Three HLA-A2 peptide tetramers able to visualize HBV core, envelope, and polymerase epitope-specific cytotoxic T lymphocytes were synthesized and used for flow cytometric analysis of antigen-specific populations. RESULTS: Tetramer-positive cells specific for the core 18-27 epitope were found at a higher frequency than those specific for polymerase 575-583 and envelope 335-343 epitopes in most patients with acute HBV. The number of HBV-specific CD8 cells was highest during the clinically acute stage of infection and decreased after recovery. These cells expressed an activated phenotype and had an impaired capacity to expand in vitro and to display cytolytic activity in response to peptide stimulation. Recovery of these functions was observed when the frequency of specific CD8 cells decreased, coincident with a progressive decrease in their expression of activation markers. CONCLUSIONS: This study provides the first ex vivo evidence that the highest frequency of circulating HBV-specific CD8 cells coincides with the clinically acute phase of hepatitis B. These cells exhibit an activated phenotype with limited further proliferative capacity that is restored during recovery.
spellingShingle Maini, M
Boni, C
Ogg, G
King, A
Reignat, S
Lee, C
Larrubia, JR
Webster, G
Mcmichael, A
Ferrari, C
Williams, R
Vergani, D
Bertoletti, A
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title_full Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title_fullStr Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title_full_unstemmed Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title_short Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
title_sort direct ex vivo analysis of hepatitis b virus specific cd8 t cells associated with the control of infection
work_keys_str_mv AT mainim directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT bonic directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT oggg directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT kinga directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT reignats directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT leec directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT larrubiajr directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT websterg directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT mcmichaela directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT ferraric directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT williamsr directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT verganid directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection
AT bertolettia directexvivoanalysisofhepatitisbvirusspecificcd8tcellsassociatedwiththecontrolofinfection